Design Considerations in the National Football League and National Football League Players Association Prescription Drug Monitoring Program: An Introduction and Overview.
Curr Sports Med Rep
; 20(11): 614-616, 2021 Nov 01.
Article
in En
| MEDLINE
| ID: mdl-34752436
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prescription Drugs
/
Football
Type of study:
Risk_factors_studies
Limits:
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
Curr Sports Med Rep
Year:
2021
Document type:
Article
Country of publication:
Estados Unidos